Budapest, Hungary

Zoltán Varga

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 1996-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Zoltán Varga: Innovator in Pharmaceutical Chemistry

Introduction

Zoltán Varga is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative methods for producing complex compounds. With a total of seven patents to his name, Varga's work has had a notable impact on the industry.

Latest Patents

One of Varga's latest patents is a method for the production of lumateperone and its salts. This method involves the separation of the enantiomer compound with stereochemistry 6bR,10aS from the cis racemate using resolution. Additionally, the formula (II) stereoisomer is alkylated with 4-halo-4'-fluoro butyrophenone (X=I, Br, Cl) to produce lumateperone or its acid addition salt. The invention also encompasses the amorphous form of the morphologically uniform p-toluenesulfonic acid salt of lumateperone, as well as the naphthalene-2-sulfonic acid salt of lumateperone, including the 1:2 stoichiometry salt formed with naphthalene-2-sulfonic acid.

Career Highlights

Throughout his career, Zoltán Varga has worked with notable companies such as Virostatics Srl and Egis Gyógyszergyár Zrt. His expertise in pharmaceutical development has positioned him as a key figure in the industry, contributing to advancements in drug formulation and production.

Collaborations

Varga has collaborated with esteemed colleagues, including Zoltán Greff and György Kéri. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.

Conclusion

Zoltán Varga's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic compounds, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…